tradingkey.logo
tradingkey.logo
Search

Tivic Health Systems Inc

TIVC
Add to Watchlist
1.400USD
0.0000.00%
Market hours ETQuotes delayed by 15 min
2.92MMarket Cap
LossP/E TTM

Tivic Health Systems Inc

1.400
0.0000.00%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Tivic Health Systems Inc

Currency: USD Updated: 2026-04-27

Key Insights

Tivic Health Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 146 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tivic Health Systems Inc's Score

Industry at a Glance

Industry Ranking
146 / 208
Overall Ranking
516 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Tivic Health Systems Inc Highlights

StrengthsRisks
Tivic Health Systems, Inc. is a diversified therapeutics company, with complementary bioelectronic and biologic product candidates in its clinical pipeline. It harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. It takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. It also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.
Undervalued
The company’s latest PE is -0.18, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 240.28K shares, increasing 30.47% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-04-27

The current financial score of Tivic Health Systems Inc is 7.09, ranking 89 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
7.09
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.37

Operational Efficiency

2.92

Growth Potential

7.95

Shareholder Returns

7.21

Tivic Health Systems Inc's Company Valuation

Currency: USD Updated: 2026-04-27

The current valuation score of Tivic Health Systems Inc is 6.75, ranking 151 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.18, which is -169.99% below the recent high of 0.12 and -744.51% above the recent low of -1.51.

Score

Industry at a Glance

Previous score
6.75
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 146/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-04-27

No earnings forecast score is currently available for Tivic Health Systems Inc. The Healthcare Equipment & Supplies industry's average is 7.80.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-04-27

The current price momentum score of Tivic Health Systems Inc is 1.78, ranking 202 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.59 and the support level at 1.02, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
1.66
Change
0.12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(0)
Neutral(1)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.068
Buy
RSI(14)
68.684
Neutral
STOCH(KDJ)(9,3,3)
90.282
Overbought
ATR(14)
0.118
High Vlolatility
CCI(14)
149.536
Buy
Williams %R
0.000
Overbought
TRIX(12,20)
1.085
Buy
StochRSI(14)
100.000
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
1.230
Buy
MA10
1.165
Buy
MA20
1.060
Buy
MA50
0.953
Buy
MA100
1.223
Buy
MA200
2.100
Sell

Institutional Confidence

Currency: USD Updated: 2026-04-27

The current institutional shareholding score of Tivic Health Systems Inc is 3.00, ranking 131 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 8.35%, representing a quarter-over-quarter decrease of 6.17%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Avenue Capital Group
101.64K
--
Geode Capital Management, L.L.C.
7.73K
--
Marex Group plc
40.94K
+6.64%
3I Management LLC
47.05K
--
Ernst (Jennifer)
32.69K
+40.62%
Susquehanna International Group, LLP
14.64K
--
Handley Michael K
8.82K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-04-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Tivic Health Systems Inc is 1.56, ranking 183 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.18. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.56
Change
0
Beta vs S&P 500 index
2.18
VaR
--
240-Day Maximum Drawdown
+83.26%
240-Day Volatility
+118.46%

Return

Best Daily Return
60 days
+18.75%
120 days
+25.08%
5 years
--
Worst Daily Return
60 days
-13.26%
120 days
-21.62%
5 years
--
Sharpe Ratio
60 days
+0.92
120 days
-0.51
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+83.26%
3 years
+99.68%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.80
3 years
-0.33
5 years
--
Skewness
240 days
+0.24
3 years
+6.70
5 years
--

Volatility

Realised Volatility
240 days
+118.46%
5 years
--
Standardised True Range
240 days
+13.14%
5 years
--
Downside Risk-Adjusted Return
120 days
-78.85%
240 days
-78.85%
Maximum Daily Upside Volatility
60 days
+127.24%
Maximum Daily Downside Volatility
60 days
+72.55%

Liquidity

Average Turnover Rate
60 days
+160.92%
120 days
+208.72%
5 years
--
Turnover Deviation
20 days
-89.18%
60 days
-96.22%
120 days
-95.09%

Peer Comparison

Healthcare Equipment & Supplies
Tivic Health Systems Inc
Tivic Health Systems Inc
TIVC
3.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI